Cargando…
Modelling metabolic diseases and drug response using stem cells and organoids
Metabolic diseases, including obesity, diabetes mellitus and cardiovascular disease, are a major threat to health in the modern world, but efforts to understand the underlying mechanisms and develop rational treatments are limited by the lack of appropriate human model systems. Notably, advances in...
Autores principales: | Hu, Wenxiang, Lazar, Mitchell A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449917/ https://www.ncbi.nlm.nih.gov/pubmed/36071283 http://dx.doi.org/10.1038/s41574-022-00733-z |
Ejemplares similares
-
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
por: Azar, Joseph, et al.
Publicado: (2021) -
Genome engineering of stem cell organoids for disease modeling
por: Sun, Yingmin, et al.
Publicado: (2017) -
Modeling Intestinal Stem Cell Function with Organoids
por: Takahashi, Toshio, et al.
Publicado: (2021) -
Modeling endodermal organ development and diseases using human pluripotent stem cell-derived organoids
por: Pan, Fong Cheng, et al.
Publicado: (2020) -
SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids
por: Trevisan, Marta, et al.
Publicado: (2021)